An approved anti-cancer drug successfully targets the first step in the toxic chain reaction that leads to Alzheimer’s disease, suggesting that treatments may be found to lower the risk of developing the neurodegenerative condition.

A bewildering physics problem has apparently been solved by researchers, in a study which provides a mathematical basis for understanding issues ranging from predicting the formation of deserts, to making artificial intelligence more efficient.

Study indicates ‘biomass burning’ may play a larger role in climate change than previously realised.

An event taking place next week in Cambridge will highlight some of the key scientific, technological and policy issues relevant to the Paris climate summit which begins later this month.

A major showcase of companies developing new technologies from graphene and other two-dimensional materials took place this week at the Cambridge Graphene Centre.

Researchers have successfully demonstrated how several of the problems impeding the practical development of the so-called ‘ultimate’ battery could be overcome.

120 fifteen-year-olds from schools across the UK recently took over a chemistry lab at Cambridge to conduct university level experiments and explore their interest in the subject. 

AstraZeneca and the University of Cambridge today announced three new joint schemes to support more than 80 PhD scholarships and eight clinical lectureships over the next five years spanning translational science, basic and clinical research. Two of the schemes are co-funded by the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge University Hospitals and University of Cambridge.

A rare DNA base, previously thought to be a temporary modification, has been shown to be stable in mammalian DNA, suggesting that it plays a key role in cellular function.